Customize your news by selecting a specialty and/or location from the lists below.
On Thursday, July 1, 2021, updates were made to the release of inpatient and pediatric notes. Inpatient notes are now released to MyChart 24 hours following signing. Despite this update, the following notes will continue to not be shared: notes
Read moreWhat You Need to Know On October 20, 2021, the CDC’s Advisory Committee on Immunization Practices (ACIP) voted to revise its adult pneumococcal vaccination recommendations. Hackensack Meridian Health supports the updated ACIP recommendations and encourages providers to vaccinate patients with
Read moreWhat You Need to Know A new report by cardiologists from the Heart & Vascular Hospital at Hackensack University Medical Center that compares the hemodynamics of cardiac shock in patients with COVID-19 during the first versus the second wave of
Read moreWhat You Need to Know Investigators from Hackensack Meridian John Theurer Cancer Center (JTCC) collaborated on a new study published in the journal Cancer Medicine. Led by researchers from Georgetown Lombardi Comprehensive Cancer Center, Results from the Thinking and Living
Read moreThe Center for Discovery and Innovation is conducting a study involving assessing neutralizing antibody levels of individuals who have received at least one dose of a COVID-19 vaccine. If you or any of your team members (or others in their
Read moreDear Colleague, If you have a patient who needs an organ transplant, you want to know that they will receive the best care from a dedicated team of organ transplantation experts, with short wait times for a deceased donor organ and
Read moreHackensack University Medical Center’s Heart and Vascular Hospital is enrolling patients in a study to treat Long COVID-19 Syndrome. Patients with shortness of breath, fatigue and rapid beating of the heart (tachycardia) will be treated with a specifically designed regimen
Read moreTo help keep our Hackensack Meridian Health Partners physicians informed about the latest pharmacy changes. This month’s issue includes: Upcoming Generic Drugs Payor Updates Updates from Aetna Statin Use in Diabetes Medication Safety: Zantac v. Zantac 360 Check out the December 2021
Read moreHMH has a new policy regarding Perioperative/Procedural Sharps Safety. The policy gives guidance to perioperative team members for identifying potential sharps hazards and developing and implementing best practices, including: use of engineered sharps to prevent sharps injuries and reduce bloodborne
Read moreWhat you need to know As part of our ongoing efforts to improve physician communications, workflow efficiency and overall experience, we are moving off the Maestro mobile app and Practice Unite as of October 29, 2021. HMH will now exclusively use
Read moreAlteplase (tPA) will no longer be used for AIS, but will be available for other indications. WHY THE SWITCH? Tenecteplase was added as an option for thrombolytic therapy in AIS in the 2019 AHA Guideline Update. Tenecteplase is given as
Read moreWhat You Need to Know Hackensack University Medical Center, Center for Memory Loss and Brain Health will be participating in a multicenter clinical trial to study the safety and efficacy of escitalopram, an antidepressant, for the treatment of agitation related
Read moreWhat You Need to Know HMH is implementing a new network policy about surrogate decision making for adult patients who lack decision making capacity. This policy details the hierarchy of surrogate decision makers who may act on behalf of adult
Read moreWhat you need to know Interventional cardiologists at Hackensack University Medical Center recently concluded a study that suggests that the mechanisms responsible for COVID-associated myocardial infarction (heart attack), may involve less extensive blockages of the blood vessels in the heart
Read moreWhat you need to know Beginning Nov. 1, 2020, patients can access most of their lab and test results via MyChart 24 hours after they are finalized, including holidays and weekends. Sensitive results, such as certain radiology, oncology and pathology
Read moreBeginning with Hackensack going live on Beaker on Sunday, November 1, 2020, physicians who need to collect a specimen for lumbar punctures, paracentesis, bronchoscopy, etc., need to ask a nurse to document the specimen collection in Epic. The correct lab
Read moreWhat you need to know A major new project is looking to engage 1,000 doctors, nurses, residents, pharmacists, case managers and others involved in the care of patients on opioids from across Hackensack Meridian Health. Participants will learn safe opioid
Read moreCooper Health Care and Rowan University are offering medication assisted treatment (MAT) training for all Hackensack Meridian Health providers. The training session is being held virtually on Tuesday, September 29, 2020, from 4 p.m. – 9:30 p.m. Training includes 9.5
Read moreWhat you need to know The U.S. Food and Drug Administration granted accelerated approval for brexucabtagene autoleucel (TECARTUS™, formerly KTE-X19) as the first and only CAR T-cell therapy for patients with mantle cell lymphoma (MCL) relapsed or refractory to prior
Read moreGet regular updates on HMH COVID-19 response, policies and protocols DO NOT UPDATE THIS PAGE. UPDATE CONTENT AT: https://hmhmaestro.org/wp-admin/post.php?post=15247&action=edit As of 12:00 p.m. on March 19, New Jersey is reporting 742 presumptive positive COVID-19 (novel coronavirus) cases and nine deaths
Read moreLast Updated: February 26, 2020 There is an ongoing issue with shortages of specific medications for hospitals in the southern region as well as Raritan Bay, Bayshore and Riverview medical centers. These supply problems have caused Hackensack Meridian Health to substitute
Read moreWhat you need to know John Theurer Cancer Center (JTCC) has launched a clinical trial for a personalized cancer vaccine that along with pembrolizumab immunotherapy will reduce the risk of relapse in patients after melanoma surgery. JTCC is the only
Read moreWhat you need to know Hackensack University Medical Center researchers in Emergency Medicine participated in a nationwide study published in the New England Journal of Medicine in November 2019 that concluded that three drugs are equally safe and effective in
Read moreWhat you need to know Investigators at John Theurer Cancer Center at Hackensack University Medical are participating in a first-in-patients clinical trial assessing VE800, a novel bacteria-containing therapy, in combination with the immunotherapy drug nivolumab. Laboratory research has suggested that
Read moreWhat you need to know Investigators at John Theurer Cancer Center (JTCC) at Hackensack University Medical Center are the first to report poor adherence to genomic profiling guidelines for four biomarkers of metastatic colorectal cancer used to predict response to
Read moreWhat you need to know Investigators at John Theurer Cancer Center at Hackensack University Medical Center in New Jersey report effectiveness of treatment in the CANDOR global phase III clinical trial for patients with refractory (persistent) multiple myeloma. The study
Read moreWhat you need to know Investigators at John Theurer Cancer Center (JTCC) at Hackensack University Medical Center were part of the 15-site international ZUMA-2 trial, a phase II study of CAR T-cell therapy in a heavily pretreated patient population who
Read moreLast updated October 7, 2019 Currently, there is a nationwide shortage of the following drugs: Related Posts Medical and Dental Staff Appointments: Central Region March 2019 Amie Thornton Promoted to Chief Operating Officer for JFK Medical Center Test caption for
Read moreWhat you need to know Joseph M. Sanzari Children’s Hospital and John Theurer Cancer Center recently launched a clinical trial evaluating gene therapy for severe sickle cell disease in adolescents and adults. This is a multicenter Phase I/II clinical trial
Read moreWhat you need to know The Division of Movement Disorders at the Departments of Neurology and Neurosurgery at Hackensack Meridian Health University Medical Center have been selected as one of multiple medical centers in the United States to participate in
Read moreSponsored by the Memorial Sloan Kettering-Hackensack Meridian Health Partnership What you need to know This funding opportunity is for projects with specific aims focusing on mechanisms of resistance or to mitigate toxicity for patients receiving immunotherapy treatment. Get details of
Read moreBy Lucrecia M. Campisi, Pharm. D Manager Care Transition Population Health What you need to know In January 2019, the American Geriatrics Society released the latest version of the Beers Criteria. A review of medication regimens for patients over 65
Read moreWhat you need to know Information last updated on May 29, 2019 The New Jersey Department of Health (NJDOH) has declared the 2019 Ocean County measles outbreak to be over. Between March 2019 and May 2019, the NJDOH confirmed 12
Read moreThe New Jersey Department of Health is warning residents about new possible measles exposures: Middlesex and Ocean Counties Exposures A New York City resident with a confirmed case of measles potentially exposed individuals in Middlesex and Ocean counties on April
Read moreWhat You Need To Know In an effort to reduce the number of opioid-related overdose deaths, the FDA has approved the first generic naloxone nasal spray for use in a community setting by individuals without medical training. The FDA is also
Read moreA Middlesex resident with a highly suspect case of measles may have exposed individuals in Monmouth County on April 17 and 19. According to the New Jersey Department of Health, anyone who visited the following locations may have been exposed
Read moreMandatory masking for team members who declined to receive the influenza vaccine ended on Monday, April 15. Free flu vaccinations continue to be offered through Occupational/Employee Health. For vaccination details and schedules please click here. Related Posts CDC Issues Flu
Read moreCurrent Measles Stats The United States is currently dealing with multiple measles outbreaks, including an outbreak in Ocean County as well as Brooklyn and New York’s Rockland County. As of April 11, 555 cases have been reported in 20 states
Read moreWhat you need to know On March 28, the Centers for Disease Control (CDC) issued an official Health Advisory regarding the recent increase in flu activity. Flu activity in the U.S. continues to be high, and the CDC expects flu
Read moreWhat You Need to Know Flu activity is high in New Jersey and the predominant strain is H1N1, for which the flu vaccine tends to be more effective than other strains. It’s not too late to vaccinate your patients. What You
Read moreWhat you need to know Drug maker Sandoz Inc. is recalling one lot of its Losartan Potassium Hydrochlorothiazide Tablets because the pills may have been contaminated with trace amounts of N-nitrosodiethylamine (NDEA), a known carcinogen. To date, no adverse events
Read moreWhat you need to know New Jersey’s measles outbreak has spread to Passaic County. There are 18 confirmed cases as of November 29, 2018 in Ocean and Passaic counties. This number could double as 17 suspected cases are currently under investigation in Ocean County. The
Read moreThe U.S. Food & Drug Administration recently approved the following drug therapies: Dermatology Seysara, with active ingredient sarecycline, to treat inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 9 years of age and older. Immunology Revcovi, with
Read moreOverview: Diabetic patients who aren’t trained on the proper use of standard pen needles are unaware that they aren’t actually injecting any insulin. What you can do: Teach patients about the differences between standard pen and safety pen needles. Diabetic
Read moreOverview: Patients on labor and delivery units have mistakenly received high doses of narcotics instead of IV antibiotics, due to look-alike infusion bags and overlooked warning labels. This can lead to death, seizures and respiratory arrest. What you can do:
Read moreWhat you need to know: Antidepressants, antibiotics and statins are among the 1,731 drugs that are the suspected primary causes of four types of severe adverse drug events. While uncommon, these events can lead to life-threatening medical emergencies and irreversible damage.
Read moreOverview: Methotrexate, a high-alert medication, has been associated with an alarming number of wrong-frequency errors, the Institute for Safe Medication Practices (ISMP) warns. Overdoses have resulted in vomiting, serious skin lesions, liver failure, renal failure and death. What you can
Read morePatients with post-traumatic stress disorder (PTSD) who are obese have an increased risk of type 2 diabetes mellitus (T2DM), according to a study published online in August by JAMA Psychiatry. Obesity represented the strongest predictor of T2DM. In the absence
Read more